Vivian Ott is a scientist in the Center for Cell Cultivation Techniques at the ZHAW Zurich University of Applied Sciences, led by Professor Ing. Regine Eibl, PhD. Her work focuses on the development, ...
Fed-batch and batch bioprocessing still dominate monoclonal antibody (mAb) production, but that must change if mAbs are to become economically viable therapeutic options. Current production techniques ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results